← Back to headlines
Lundbeck Reports Early Success for Experimental Cushing's Disease Treatment
Pharmaceutical company Lundbeck has announced early positive results for its experimental treatment for Cushing's disease, a rare endocrine disorder.
14 Jun, 20:24 — 14 Jun, 20:24
Sources
Showing 1 of 1 sources
Related Stories
Health Authorities Issue West Nile Virus Warnings Amid Rising Temperatures
36m ago
Cyclospora Outbreak Linked to Iceberg Lettuce Expands to Three Additional States
9h ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
12h ago
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
16h ago